Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: Insights from the GALACTIC-HF trial.
29 June 2021 (08:00 - 08:00)
Organised by:
Slides
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
13 More presentations in this session
Associate Professor C. DeFilippi (Baltimore, US)
Professor S. Stewart (Fremantle, AU)
Professor F. Koehler (Berlin, DE)
Access the full session
The Event
Heart Failure 2021
29 June 2021
08:00 CET
